Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China
Min Liu, Honghong Yang, Qian Liu, Kun He, Jing Yuan, Yaokai Chen · 2024
Read Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China by Min Liu, Honghong Yang, Qian Liu, Kun He, Jing Yuan, Yaokai Chen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11653854.txt.
Description
Talaromycosis is a fungal infection striking people with HIV, and the standard drug for it, amphotericin B deoxycholate, can damage the kidneys. Min Liu and co-authors compared a formulation, a colloidal dispersion of the drug, against the standard in a Chinese hospital cohort treated between 2018 and 2022. Thirty-eight patients received the dispersion and thirty-three the standard drug. The team compared how fast the fungus cleared, symptoms eased, and side effects differed.
Both groups cleared the fungus fully by two weeks. Symptom relief at two weeks was higher with the dispersion, near ninety-five percent against seventy-six percent. Kidney strain told the sharper story: a kidney marker rose under the standard drug but not under the dispersion. Fewer dispersion patients stopped treatment or developed low white cell counts. The authors conclude the dispersion works as well as the standard drug with less toxicity.
Catalog record
| CREATOR | Min Liu, Honghong Yang, Qian Liu, Kun He, Jing Yuan, Yaokai Chen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |